我们的淘大 @淘沙见金 早在7月份就认为ZGNX低估,并建议买入。ht...查看全文
淘沙见金2017-09-29 19:05
$Zogenix, Inc.(ZGNX)$ Zogenix Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
查看全文
Efficacious2017-09-29 13:30
预测摘要
1. ZGNX-ZX008第一个三期临床试验 0.8mg/kg高剂量组80%以上概率会达到主要临床终点。
2. 0.2 mg/kg低剂量组不一定达到主要临床终点。
3. 市场反应未知。
Zogenix是一家研究治疗儿童Dravet syndrome的公司。Dravet syndrome目前无药可治。Zogenix旗下的ZX008...查看全文
近日,比利时药商优时比(UCB)与一家位于美国加州的生物技术公司 Zogenix 共同宣布达成一项协议,优时比将以 26 美元每股 现金收购 Zogenix,此收购价格较消息宣布前一天的收盘价 15.64 美元的股票溢价约 66% ,较 Zogenix 股票过去一个月的平... 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010316 Size: 16 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010309 Size: 22 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010310 Size: 10 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010312 Size: 20 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010301 Size: 23 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010303 Size: 11 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010304 Size: 14 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010289 Size: 30 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010294 Size: 15 KB 网页链接
$Zogenix(ZGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-010293 Size: 14 KB 网页链接